Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial

NCT07101588 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Interventions

COMBINATION_PRODUCT: Ruxolitinib, Decitabine

Sponsor

Chinese PLA General Hospital

Collaborators

[object Object]
[object Object]